Clinical Study | Office of Clinical Research

A Phase 1, Multiple-Dose, Open-Label Study To Evaluate The Safety,Tolerability, And Pharmacokinetics Of Olz/Sam In Pediatric Subjects (10-12 Years Old) With Bipolar I Disorder

Posted Date: Jun 15, 2021

Investigator: Melissa Delbello
Specialties: Bipolar Disorder, Psychiatry/Psychology
Type of Study: Drug

A study to evaluate the safety, tolerability, and pharmacokinetics of the study drug in pediatric subjects (10 to 12 years old) with bipolar I disorder.

Criteria:

10-12 Year Old With Bipolar I Disorder

Keywords:

Bipolar I Disorder, Pk, Pediatric

For More Information:

Raechel Cooley, B.A
513-558-6205
cooleyra@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List